Targeting Urease: A Promising Adjuvant Strategy for Effective Helicobacter pylori Eradication.

Area of Science:

• Microbiology
• Biochemistry
• Pharmacology

Background:

• Gram-negative bacteria adapt to acidic gastric environments using urease enzyme.
• Urease neutralizes stomach acid, enabling bacterial survival, tissue invasion, and pathogenesis (gastritis, ulcers, cancer).
• Current antibiotic therapies often fail due to bacterial resistance factors like coccoid form, high load, and biofilms.

Purpose of the Study:

• To review the urease enzyme's structure and role in bacterial pathogenesis.
• To discuss existing urease inhibitors and their pharmacophoric features.
• To identify future research directions for developing potent urease inhibitors.

Main Methods:

• Literature review of urease enzyme structure, function, and inhibition.
• Analysis of pharmacophoric features of known urease inhibitors.
• Discussion of computational approaches like pharmacophore-based screening and docking studies.

Main Results:

• Urease is crucial for bacterial survival and virulence in the stomach.
• Inhibiting urease can reduce bacterial pathogenicity and enhance antibiotic susceptibility.
• Existing inhibitors have diverse pharmacophoric characteristics.

Conclusions:

• Targeting urease activity is a promising strategy to combat bacterial infections and antibiotic resistance.
• Adjuvant therapy with urease inhibitors and antibiotics may improve eradication rates.
• Further research, including computational screening of scaffolds like chlorogenic acid, catechol, and hydroxamic acid, is needed to discover novel urease inhibitors.